Regarding the involvement of ABC transporters, they have also been described, by metagenome and metatranscriptome sequencing, as in active expression in GM of COVID-19 patients along with beta-lactam resistance metabolic pathways (Zhou et al., 2022). This evidence concerns the gene ABCG2 and COVID-19.